Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Peripartum Cardiomyopathies Using Artificial Intelligence (SPEC-AI) in Nigeria

NCT05438576 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05438576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05438576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Peripartum Cardiomyopathies Using Artificial Intelligence (SPEC-AI) in Nigeria
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2022
Completion date
May 15, 2024
Enrollment
1,232 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, pregnancy related